Showing content from https://patents.google.com/patent/SG11202100092QA/en below:
SG11202100092QA - USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONRIAL DISORDERS
JP2928079B2 (en) 1994-02-14 1999-07-28 永信è¬åå·¥æ¥è¡â²ãµãâ¼æéå
¬å¸ 1- (Substituted benzyl) -3- (substituted aryl) condensed pyrazoles, their production and use EP1686127A1 (en) 1996-10-14 2006-08-02 Bayer HealthCare AG New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases DE19642255A1 (en) 1996-10-14 1998-04-16 Bayer Ag Use of 1-benzyl-3- (substituted-hetaryl) fused pyrazole derivatives DE19649460A1 (en) 1996-11-26 1998-05-28 Bayer Ag New substituted pyrazole derivatives DE19744026A1 (en) 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazole derivatives, their preparation and their use in medicinal products EP1614678B1 (en) 1998-07-08 2014-01-01 Sanofi-Aventis Deutschland GmbH Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them DE19830430A1 (en) 1998-07-08 2000-01-13 Hoechst Marion Roussel De Gmbh New sulfur-substituted sulfonylamino-carboxylic acid N-arylamide derivatives useful as guanylate cyclase activators in treatment of e.g. cardiovascular disorders, asthma and diabetes DE19834045A1 (en) 1998-07-29 2000-02-03 Bayer Ag (4-Amino-5-ethylpyrimidin-2-yl) -1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine DE19834047A1 (en) 1998-07-29 2000-02-03 Bayer Ag Substituted pyrazole derivatives DE19834044A1 (en) 1998-07-29 2000-02-03 Bayer Ag New substituted pyrazole derivatives DE19846514A1 (en) 1998-10-09 2000-04-20 Bayer Ag New arylmethyl and heterocyclylmethyl substituted heteroaryl-indazole derivatives useful in treatment of cardiovascular, ischemic and urogenital disorders GB9824310D0 (en) 1998-11-05 1998-12-30 Univ London Activators of soluble guanylate cyclase DE19920352A1 (en) 1999-05-04 2000-11-09 Bayer Ag Substituted pyrazole derivative DE19942809A1 (en) 1999-09-08 2001-03-15 Bayer Ag Process for the preparation of substituted pyrimidine derivatives DE19943635A1 (en) 1999-09-13 2001-03-15 Bayer Ag Novel aminodicarboxylic acid derivatives with pharmaceutical properties DE19962926A1 (en) 1999-12-24 2001-06-28 Bayer Ag Comminution of a substance, especially a cardiovascular drug, comprises mixing the substance with lactose and comminuting the mixture in a jet mill DE10021069A1 (en) 2000-04-28 2001-10-31 Bayer Ag Substituted pyrazole derivative DE10054278A1 (en) 2000-11-02 2002-05-08 Bayer Ag Use of soluble guanylate cyclase stimulators for the treatment of osteoporosis DE10057751A1 (en) 2000-11-22 2002-05-23 Bayer Ag New carbamate-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation DE10057754A1 (en) 2000-11-22 2002-05-23 Bayer Ag New cyclic sulfonamido-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation AR031176A1 (en) 2000-11-22 2003-09-10 Bayer Ag NEW DERIVATIVES OF PIRAZOLPIRIDINA SUBSTITUTED WITH PIRIDINE DE10122894A1 (en) 2001-05-11 2002-11-14 Bayer Ag New pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl sulfonates, are soluble guanyl cyclase stimulants useful e.g. for treating cardiovascular, thromboembolic or central nervous system diseases DE10132416A1 (en) 2001-07-04 2003-01-16 Bayer Ag New morpholine-bridged pyrazolopyridine derivatives DE10216145A1 (en) 2002-04-12 2003-10-23 Bayer Ag Use of stimulators of soluble guanylate cyclase to produce a medicament for treating glaucoma DE10220570A1 (en) 2002-05-08 2003-11-20 Bayer Ag Carbamate-substituted pyrazolopyridines DE10222550A1 (en) 2002-05-17 2003-11-27 Bayer Ag New 1-benzyl-3-(2-pyrimidinyl)-pyrazolo-(3,4-b)-pyridine derivatives are soluble guanylate cyclase stimulants, useful e.g. for treating cardiovascular or thromboembolic diseases or sexual dysfunction DE10232571A1 (en) 2002-07-18 2004-02-05 Bayer Ag 4-amino substituted pyrimidine derivatives DE10232572A1 (en) 2002-07-18 2004-02-05 Bayer Ag New 2,5-disubstituted pyrimidine derivatives DE10242941A1 (en) 2002-09-16 2004-03-18 Bayer Ag New 2-(pyrazolo-(3,4-b)-pyridinyl)-5-pyridinyl-4-pyrimidinylamine derivative, is a soluble guanylate cyclase stimulant useful e.g. for treating cardiovascular diseases, hypertension or ischemia DE10244810A1 (en) 2002-09-26 2004-04-08 Bayer Ag New morpholine-bridged indazole derivatives US20070148136A1 (en) 2003-09-26 2007-06-28 Whitlock David R Methods of using ammonia oxidizing bacteria WO2005084660A1 (en) * 2004-03-05 2005-09-15 Morishige, Fumie Prevention and measure for mitochondrial disease DE102006020327A1 (en) 2006-04-27 2007-12-27 Bayer Healthcare Ag Heterocyclic substituted, fused pyrazole derivatives and their use DE102006021733A1 (en) 2006-05-09 2007-11-22 Bayer Healthcare Ag 3-tetrazolylindazoles and 3-tetrazolylpyrazolopyridines and their use DE102006043443A1 (en) 2006-09-15 2008-03-27 Bayer Healthcare Ag Novel aza-bicyclic compounds and their use DE102006054757A1 (en) 2006-11-21 2008-05-29 Bayer Healthcare Ag Novel aza-bicyclic compounds and their use EP2150616A4 (en) 2007-05-10 2011-07-27 Univ Arizona REGULATED EXPRESSION OF ANTIGEN AND / OR REGULATED MITIGATION TO INCREASE VACCINE IMMUNOGENICITY AND / OR SAFETY BRPI0816382A2 (en) 2007-09-06 2015-02-24 Merck Sharp & Dohme COMPOUND, COMPOSITION, AND METHODS TO ACTIVATE SOLUBLE GUANILATE CYCLASE AND TO TREAT OR PREVENT DISEASES US8397065B2 (en) 2007-10-17 2013-03-12 Telcordia Technologies, Inc. Secure content based routing in mobile ad hoc networks JP2011510082A (en) 2008-01-24 2011-03-31 ã¡ã«ã¯ã»ã·ã£ã¼ãã»ã¨ã³ãã»ãã¼ã ã»ã³ã¼ãã¬ã¤ã·ã§ã³ Angiotensin II receptor antagonist US8741910B2 (en) 2008-11-25 2014-06-03 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators DE102008063992A1 (en) 2008-12-19 2010-09-02 Lerner, Zinoviy, Dipl.-Ing. New aliphatic substituted pyrazolopyridines and their use DE102009004245A1 (en) 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Novel fused, heteroatom-bridged pyrazole and imidazole derivatives and their use KR20110133034A (en) 2009-02-26 2011-12-09 ë¨¸í¬ ì¤í ì¤ë ë ì½í¬ë ì´ì
Soluble Guanylate Cyclase Activator UY33041A (en) 2009-11-27 2011-06-30 Bayer Schering Pharma Aktienegesellschaft PROCEDURE FOR THE PREPARATION OF {4,6-DIAMINO-2- [1- (2-FLUOROBENCIL) -1H-PIRAZOLO [3,4-B] PIRIDIN-3-IL] PIRIMIDIN-5-IL} CARBAMATO DE METTILO AND ITS PURIFICATION FOR USE AS A PHARMACEUTICAL ACTIVE PRINCIPLE EA022813B1 (en) 2009-11-27 2016-03-31 ÐдвеÑио ФаÑма ÐмбÑ
METHOD FOR PURIFYING METHYL{4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-b]PYRIDINO-3-YL]PYRIMIDINO-5-YL}METHYL CARBAMATE AND A DERIVATIVE THEREOF AS SULFINYLDIMETHANE BR112012014320A2 (en) 2009-12-14 2016-07-05 Bayer Intellectual Propertry Gmbh new methyl {4,6-diamino-2- [1- (2-fluorobenzyl) -1h-pyrazolo [3,4-b] pyridin-3-yl) pyrimidin-5-yl} carbamate solvates US20130178475A1 (en) 2010-03-17 2013-07-11 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS US9284301B2 (en) 2010-03-25 2016-03-15 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators KR20200047642A (en) 2010-04-23 2020-05-07 ì ëë²ìí° ì¤ë¸ íë¡ë¦¬ë¤ 리ìì¹ íì´ë°ì´ì
, ì¸í¬. Raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1) DE102010021637A1 (en) 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituted 5-fluoro-1H-pyrazolopyridines and their use SI2576548T1 (en) 2010-05-26 2015-11-30 Adverio Pharma Gmbh THE USE OF sGC STIMULATORS, sGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS (SSc) BR112012030177B1 (en) 2010-05-27 2019-08-27 Merck Sharp & Dohme soluble guanylate cyclase activating compound and pharmaceutical composition DK2588465T3 (en) 2010-06-30 2017-05-01 Ironwood Pharmaceuticals Inc SGC stimulators CN103180327B (en) 2010-07-09 2016-08-10 æè³ç¥è¯äº§ææé责任å
¬å¸ The 4-aminopyrimidine of condensed ring and the purposes of the stimulus object as the sweet cyclase of acid of solubility bird thereof US9216978B2 (en) 2010-07-09 2015-12-22 Bayer Intellectual Property Gmbh Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases DE102010031667A1 (en) 2010-07-22 2012-01-26 Bayer Schering Pharma Aktiengesellschaft Substituted methyl pyrimidin-5-ylcarbamates and their use DE102010031665A1 (en) 2010-07-22 2012-01-26 Bayer Schering Pharma Aktiengesellschaft Substituted oxazolidinones and oxazinones and their use DE102010040233A1 (en) 2010-09-03 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Bicyclic aza heterocycles and their use WO2012058132A1 (en) 2010-10-28 2012-05-03 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators DE102010043379A1 (en) 2010-11-04 2012-05-10 Bayer Schering Pharma Aktiengesellschaft Substituted 6-fluoro-1H-pyrazolo [4,3-b] pyridines and their use NZ609955A (en) 2010-11-09 2015-05-29 Ironwood Pharmaceuticals Inc Sgc stimulators WO2012152629A1 (en) 2011-05-06 2012-11-15 Bayer Intellectual Property Gmbh Substituted imidazopyridines and imidazopyridazines and the use thereof ES2583086T3 (en) 2011-04-21 2016-09-19 Bayer Intellectual Property Gmbh Pyrazolopyridines substituted with fluoroalkyl and their use DE102011075398A1 (en) 2011-05-06 2012-11-08 Bayer Pharma Aktiengesellschaft Substituted imidazopyridazines and their use PH12013502419A1 (en) 2011-05-30 2014-01-06 Astellas Pharma Inc Imidazopyridine compounds CA2840886A1 (en) 2011-07-06 2013-01-10 Bayer Intellectual Property Gmbh Heteroaryl-substituted pyrazolopyridines and use thereof as soluble guanylate cyclase stimulators CA2847075A1 (en) 2011-09-02 2013-03-07 Bayer Intellectual Property Gmbh Substituted annellated pyrimidine and the use thereof PE20190180A1 (en) 2011-11-25 2019-02-01 Adverio Pharma Gmbh PROCEDURE FOR THE PREPARATION OF 5-FLUORO-1H-PYRAZOLOPYRIDINES SUBSTITUTED CN102491974B (en) 2011-12-12 2013-08-07 å京è¯ç³è¯ç©ç åæéå
¬å¸ Method for synthesizing 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-formamidine hydrochloride EP2797915B1 (en) 2011-12-27 2016-07-13 Ironwood Pharmaceuticals, Inc. 2-benzyl-3-(oxazole/thiazole)-5-(pyrimidin-2-yl)-1(H)-pyrazole derivatives as stimulators of the soluble guanylate cyclase (sGC) for the treatment of e.g. hypertension or heart failure DE102012200352A1 (en) 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituted, fused imidazoles and pyrazoles and their use DE102012200349A1 (en) 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituted fused pyrimidines and triazines and their use DE102012200360A1 (en) 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituted triazines and their use CA2866213A1 (en) 2012-03-06 2013-09-12 Bayer Intellectual Property Gmbh Substituted azabicycles and use thereof WO2014047111A1 (en) 2012-09-18 2014-03-27 Ironwood Pharmaceuticals, Inc. Sgc stimulators EP2897953B8 (en) 2012-09-19 2019-06-26 Cyclerion Therapeutics, Inc. Sgc stimulators US8796305B2 (en) 2012-11-05 2014-08-05 Bayer Pharma Aktiengesellschaft Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use US9624214B2 (en) 2012-11-05 2017-04-18 Bayer Pharma Aktiengesellschaft Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use US8778964B2 (en) 2012-11-05 2014-07-15 Bayer Pharma Aktiengesellschaft Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use AU2013353117A1 (en) 2012-11-30 2015-06-04 Astellas Pharma Inc. Imidazopyridine compound US20150376184A1 (en) 2013-02-21 2015-12-31 Adverio Pharma Gmbh Forms of methyl methyl carbamate CA2902987A1 (en) 2013-03-01 2014-09-04 Bayer Pharma Aktiengesellschaft Benzyl-substituted pyrazolopyridines and use thereof MX2015010966A (en) 2013-03-01 2016-04-04 Bayer Pharma AG Trifluormethyl-substituted ring-fused pyrimidines and use thereof. EA031746B1 (en) 2013-03-15 2019-02-28 ÐйÑонвÑд ФаÑмаÑÑÑÑикалз, Ðнк. STIMULATORS OF sGC US9776997B2 (en) 2013-06-04 2017-10-03 Bayer Pharma Aktiengesellschaft 3-aryl-substituted imidazo[1,2-A]pyridines and their use WO2015018814A1 (en) 2013-08-08 2015-02-12 Bayer Pharma Aktiengesellschaft Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof US20160256460A1 (en) 2013-11-01 2016-09-08 Bergen Teknologioverføring As Activators or stimulators of soluble guanylate cyclase for use in treating chronic fatigue syndrome US20160362408A1 (en) 2013-12-05 2016-12-15 Bayer Pharma Aktiengesellschaft Aryl- and hetaryl-substituted imidazo[1,2-a]pyridine-3-carboxamides and use thereof CN106304835A (en) 2013-12-11 2017-01-04 éæ¨å»è¯æéå
¬å¸ Sgc stimulant EP3079701B1 (en) 2013-12-11 2021-08-11 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators EP3079700B1 (en) 2013-12-11 2020-11-25 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators US9688699B2 (en) 2014-02-19 2017-06-27 Bayer Pharma Aktiengesellschaft 3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines HK1225723A1 (en) 2014-03-21 2017-09-15 Bayer Pharma Aktiengesellschaft Substituted imidazo[1,2-a]pyridinecarboxamides and their use JP2017508810A (en) 2014-03-21 2017-03-30 ãã¤ã¨ã«ã»ãã¡ã«ãã»ã¢ã¯ãã£ã¨ã³ã²ã¼ã«ã·ã£ãã Cyano-substituted imidazo [1,2-a] pyridinecarboxamide and uses thereof WO2015150364A1 (en) 2014-04-03 2015-10-08 Bayer Pharma Aktiengesellschaft Substituted benzotriazinone butane acids and use thereof JP2017509665A (en) 2014-04-03 2017-04-06 ãã¤ã¨ã« ãã¡ã¼ã ã¢ã¯ãã¨ã³ã²ã¼ã«ã·ã£ãã 2,5-Disubstituted cyclopentanecarboxylic acids for the treatment of airway diseases WO2015150366A1 (en) 2014-04-03 2015-10-08 Bayer Pharma Aktiengesellschaft Cyclically substituted phenol ether derivatives and use thereof WO2015150363A1 (en) 2014-04-03 2015-10-08 Bayer Pharma Aktiengesellschaft 2,5-disubstituted cyclopentane carboxylic acids and use thereof CA2944617A1 (en) 2014-04-03 2015-10-08 Bayer Pharma Aktiengesellschaft Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof US20170298055A1 (en) 2014-09-17 2017-10-19 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS JP2017527604A (en) 2014-09-17 2017-09-21 ã¢ã¤ã¢ã³ã¦ãã ãã¡ã¼ãã·ã¥ã¼ãã£ã«ã«ãº ã¤ã³ã³ã¼ãã¬ã¤ããã sGC stimulant MX2017003516A (en) 2014-09-17 2017-07-28 Ironwood Pharmaceuticals Inc Pyrazole derivatives as sgc stimulators. AU2015317818A1 (en) 2014-09-17 2017-03-23 Ironwood Pharmaceuticals, Inc. SGC stimulators US20170014417A1 (en) * 2015-07-14 2017-01-19 Lipp Life Sciences Llc Pharmaceutical administration system for the transdermal application of vardenafil EA201891416A1 (en) * 2015-12-14 2018-12-28 ÐйÑонвÑд ФаÑмаÑÑÑÑикалз, Ðнк. APPLICATION of sGC STIMULATORS FOR THE TREATMENT OF GASTRIC AND INTESTINAL SPINKLIN TREATMENT JP2019505343A (en) 2015-12-28 2019-02-28 ãã ãã¤ãªãã㯠ã¨ã«ã¨ã«ã·ã¼ Method and apparatus for administering nitric oxide with supplemental drugs BR112018015718A2 (en) 2016-02-01 2019-01-08 Ironwood Pharmaceuticals Inc use of sgc stimulators for the treatment of nonalcoholic steatohepatitis (nash) MA45592A (en) 2016-07-07 2019-05-15 Ironwood Pharmaceuticals Inc SBS STIMULATOR PHOSPHORUS MEDICINAL PRODUCTS ES2885003T3 (en) 2016-09-02 2021-12-13 Cyclerion Therapeutics Inc Bicyclic fused SGC stimulators AU2017356887B2 (en) 2016-11-08 2022-06-30 Cyclerion Therapeutics, Inc. sGC stimulators EA201991147A1 (en) 2016-11-08 2019-11-29 TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM USING sGC STIMULANTS CN111712247B (en) 2017-12-19 2024-02-09 å¡ç§éæå»çè¡ä»½æéå
¬å¸ sGC stimulants MX2023004858A (en) * 2018-03-07 2023-11-24 Cyclerion Therapeutics Inc Crystalline forms of an sgc stimulator. AU2019301683B9 (en) 2018-07-11 2025-04-24 Tisento Therapeutics Inc. Use of sGC stimulators for the treatment of mitochondrial disorders
RetroSearch is an open source project built by @garambo
| Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4